Lepromatous leprosy in a kidney transplant recipient

A case report

Mohammadreza Ardalan, Alireza Ghaffari, Kamyar Ghabili, Mohammadali Mohajel Shoja

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Leprosy is a chronic granulomatous disease of the skin and peripheral nerves caused by Mycobacterium leprae. Among mycobacterial infections, leprosy is rare in renal transplant recipients. Here, we report the manifestations of lepromatous leprosy in a 41-year-old renal transplant recipient. Before the renal transplant, the patient had recurrent bullous lesions on his extremities with no systemic complaints. He was on an immunosuppressive regimen that included prednisolone (1 mg/kg/d), cyclosporine (6 mg/kg), and mycophenolate mofetil (2000 mg/d), and had 2 serologically confirmed acute episodes of cytomegalovirus infection that responded favorably to intravenous ganciclovir. The density of his bullous skin lesions decreased after renal transplant. During his regular posttransplant visits, we noticed a decrease in his eyebrow hairs on their lateral margins bilaterally. Later, he developed generalized, symmetric, erythematous papules. With a positive acid-fast bacilli with Fite staining, the results of a skin biopsy showed diffuse foamy histiocyte infiltration in the dermis. These findings are compatible with lepromatous leprosy. After antileprosy therapy, no deterioration of renal allograft function or lepra reactions was noted in a 4-month follow-up. Clinicians should consider leprosy in the differential diagnosis of skin lesions in immunocompromised hosts, and in particular, solid organ transplant recipients in endemic areas.

Original languageEnglish (US)
Pages (from-to)203-206
Number of pages4
JournalExperimental and Clinical Transplantation
Volume9
Issue number3
StatePublished - Jun 1 2011
Externally publishedYes

Fingerprint

Lepromatous Leprosy
Kidney
Leprosy
Skin
Blister
Transplants
Mycophenolic Acid
Eyebrows
Chronic Granulomatous Disease
Mycobacterium leprae
Ganciclovir
Histiocytes
Cytomegalovirus Infections
Immunocompromised Host
Immunosuppressive Agents
Dermis
Prednisolone
Peripheral Nerves
Hair
Bacillus

Keywords

  • Bullous
  • Multidrug therapy
  • Mycobacterium leprae
  • Renal
  • Transplant

ASJC Scopus subject areas

  • Transplantation

Cite this

Ardalan, M., Ghaffari, A., Ghabili, K., & Mohajel Shoja, M. (2011). Lepromatous leprosy in a kidney transplant recipient: A case report. Experimental and Clinical Transplantation, 9(3), 203-206.

Lepromatous leprosy in a kidney transplant recipient : A case report. / Ardalan, Mohammadreza; Ghaffari, Alireza; Ghabili, Kamyar; Mohajel Shoja, Mohammadali.

In: Experimental and Clinical Transplantation, Vol. 9, No. 3, 01.06.2011, p. 203-206.

Research output: Contribution to journalArticle

Ardalan, M, Ghaffari, A, Ghabili, K & Mohajel Shoja, M 2011, 'Lepromatous leprosy in a kidney transplant recipient: A case report', Experimental and Clinical Transplantation, vol. 9, no. 3, pp. 203-206.
Ardalan M, Ghaffari A, Ghabili K, Mohajel Shoja M. Lepromatous leprosy in a kidney transplant recipient: A case report. Experimental and Clinical Transplantation. 2011 Jun 1;9(3):203-206.
Ardalan, Mohammadreza ; Ghaffari, Alireza ; Ghabili, Kamyar ; Mohajel Shoja, Mohammadali. / Lepromatous leprosy in a kidney transplant recipient : A case report. In: Experimental and Clinical Transplantation. 2011 ; Vol. 9, No. 3. pp. 203-206.
@article{fe46724b9cf349278dfb9b0eb52cae1e,
title = "Lepromatous leprosy in a kidney transplant recipient: A case report",
abstract = "Leprosy is a chronic granulomatous disease of the skin and peripheral nerves caused by Mycobacterium leprae. Among mycobacterial infections, leprosy is rare in renal transplant recipients. Here, we report the manifestations of lepromatous leprosy in a 41-year-old renal transplant recipient. Before the renal transplant, the patient had recurrent bullous lesions on his extremities with no systemic complaints. He was on an immunosuppressive regimen that included prednisolone (1 mg/kg/d), cyclosporine (6 mg/kg), and mycophenolate mofetil (2000 mg/d), and had 2 serologically confirmed acute episodes of cytomegalovirus infection that responded favorably to intravenous ganciclovir. The density of his bullous skin lesions decreased after renal transplant. During his regular posttransplant visits, we noticed a decrease in his eyebrow hairs on their lateral margins bilaterally. Later, he developed generalized, symmetric, erythematous papules. With a positive acid-fast bacilli with Fite staining, the results of a skin biopsy showed diffuse foamy histiocyte infiltration in the dermis. These findings are compatible with lepromatous leprosy. After antileprosy therapy, no deterioration of renal allograft function or lepra reactions was noted in a 4-month follow-up. Clinicians should consider leprosy in the differential diagnosis of skin lesions in immunocompromised hosts, and in particular, solid organ transplant recipients in endemic areas.",
keywords = "Bullous, Multidrug therapy, Mycobacterium leprae, Renal, Transplant",
author = "Mohammadreza Ardalan and Alireza Ghaffari and Kamyar Ghabili and {Mohajel Shoja}, Mohammadali",
year = "2011",
month = "6",
day = "1",
language = "English (US)",
volume = "9",
pages = "203--206",
journal = "Experimental and Clinical Transplantation",
issn = "1304-0855",
publisher = "Baskent University",
number = "3",

}

TY - JOUR

T1 - Lepromatous leprosy in a kidney transplant recipient

T2 - A case report

AU - Ardalan, Mohammadreza

AU - Ghaffari, Alireza

AU - Ghabili, Kamyar

AU - Mohajel Shoja, Mohammadali

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Leprosy is a chronic granulomatous disease of the skin and peripheral nerves caused by Mycobacterium leprae. Among mycobacterial infections, leprosy is rare in renal transplant recipients. Here, we report the manifestations of lepromatous leprosy in a 41-year-old renal transplant recipient. Before the renal transplant, the patient had recurrent bullous lesions on his extremities with no systemic complaints. He was on an immunosuppressive regimen that included prednisolone (1 mg/kg/d), cyclosporine (6 mg/kg), and mycophenolate mofetil (2000 mg/d), and had 2 serologically confirmed acute episodes of cytomegalovirus infection that responded favorably to intravenous ganciclovir. The density of his bullous skin lesions decreased after renal transplant. During his regular posttransplant visits, we noticed a decrease in his eyebrow hairs on their lateral margins bilaterally. Later, he developed generalized, symmetric, erythematous papules. With a positive acid-fast bacilli with Fite staining, the results of a skin biopsy showed diffuse foamy histiocyte infiltration in the dermis. These findings are compatible with lepromatous leprosy. After antileprosy therapy, no deterioration of renal allograft function or lepra reactions was noted in a 4-month follow-up. Clinicians should consider leprosy in the differential diagnosis of skin lesions in immunocompromised hosts, and in particular, solid organ transplant recipients in endemic areas.

AB - Leprosy is a chronic granulomatous disease of the skin and peripheral nerves caused by Mycobacterium leprae. Among mycobacterial infections, leprosy is rare in renal transplant recipients. Here, we report the manifestations of lepromatous leprosy in a 41-year-old renal transplant recipient. Before the renal transplant, the patient had recurrent bullous lesions on his extremities with no systemic complaints. He was on an immunosuppressive regimen that included prednisolone (1 mg/kg/d), cyclosporine (6 mg/kg), and mycophenolate mofetil (2000 mg/d), and had 2 serologically confirmed acute episodes of cytomegalovirus infection that responded favorably to intravenous ganciclovir. The density of his bullous skin lesions decreased after renal transplant. During his regular posttransplant visits, we noticed a decrease in his eyebrow hairs on their lateral margins bilaterally. Later, he developed generalized, symmetric, erythematous papules. With a positive acid-fast bacilli with Fite staining, the results of a skin biopsy showed diffuse foamy histiocyte infiltration in the dermis. These findings are compatible with lepromatous leprosy. After antileprosy therapy, no deterioration of renal allograft function or lepra reactions was noted in a 4-month follow-up. Clinicians should consider leprosy in the differential diagnosis of skin lesions in immunocompromised hosts, and in particular, solid organ transplant recipients in endemic areas.

KW - Bullous

KW - Multidrug therapy

KW - Mycobacterium leprae

KW - Renal

KW - Transplant

UR - http://www.scopus.com/inward/record.url?scp=79958760940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958760940&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 203

EP - 206

JO - Experimental and Clinical Transplantation

JF - Experimental and Clinical Transplantation

SN - 1304-0855

IS - 3

ER -